Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.053 | 0.4 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |